New insights into the pathophysiology of irritable bowel syndrome: Implications for future treatments

Michael D. Crowell, Lucinda Harris, Michael P. Jones, Lin Chang

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Irritable bowel syndrome (IBS) is a multifactorial disorder characterized by abdominal pain and altered bowel habits. Chronic symptoms may occur due to changes in gastrointestinal motor function, enhanced perception of gut stimuli, and psychosocial factors. Recent data suggest that abnormal processing of afferent signals occurs in IBS patients. A newly recognized causative factor in a subset of IBS patients is postinfectious IBS. Altered transport of intestinal gas and bowel distention may contribute to abdominal discomfort, pain, and bloating. Changes in gut microflora have also been reported, but data remain scant. Advances have been made in our understanding of serotonin signaling and metabolism in IBS patients, in part due to the introduction of specific receptor agonists and antagonists. Finally, exciting data are emerging on genetic alterations that may contribute to the pathophysiology and treatment of IBS. Increasingly novel mechanisms are being identified that should aid in better understanding of the complex pathophysiology of IBS and developing new therapies.

Original languageEnglish (US)
Pages (from-to)272-279
Number of pages8
JournalCurrent Gastroenterology Reports
Volume7
Issue number4
StatePublished - Aug 2005

Fingerprint

Irritable Bowel Syndrome
proctolin
Abdominal Pain
Therapeutics
Habits
Serotonin
Gases
Psychology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

New insights into the pathophysiology of irritable bowel syndrome : Implications for future treatments. / Crowell, Michael D.; Harris, Lucinda; Jones, Michael P.; Chang, Lin.

In: Current Gastroenterology Reports, Vol. 7, No. 4, 08.2005, p. 272-279.

Research output: Contribution to journalArticle

Crowell, Michael D. ; Harris, Lucinda ; Jones, Michael P. ; Chang, Lin. / New insights into the pathophysiology of irritable bowel syndrome : Implications for future treatments. In: Current Gastroenterology Reports. 2005 ; Vol. 7, No. 4. pp. 272-279.
@article{c9e260945222424b85aa4136fd447c6c,
title = "New insights into the pathophysiology of irritable bowel syndrome: Implications for future treatments",
abstract = "Irritable bowel syndrome (IBS) is a multifactorial disorder characterized by abdominal pain and altered bowel habits. Chronic symptoms may occur due to changes in gastrointestinal motor function, enhanced perception of gut stimuli, and psychosocial factors. Recent data suggest that abnormal processing of afferent signals occurs in IBS patients. A newly recognized causative factor in a subset of IBS patients is postinfectious IBS. Altered transport of intestinal gas and bowel distention may contribute to abdominal discomfort, pain, and bloating. Changes in gut microflora have also been reported, but data remain scant. Advances have been made in our understanding of serotonin signaling and metabolism in IBS patients, in part due to the introduction of specific receptor agonists and antagonists. Finally, exciting data are emerging on genetic alterations that may contribute to the pathophysiology and treatment of IBS. Increasingly novel mechanisms are being identified that should aid in better understanding of the complex pathophysiology of IBS and developing new therapies.",
author = "Crowell, {Michael D.} and Lucinda Harris and Jones, {Michael P.} and Lin Chang",
year = "2005",
month = "8",
language = "English (US)",
volume = "7",
pages = "272--279",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - New insights into the pathophysiology of irritable bowel syndrome

T2 - Implications for future treatments

AU - Crowell, Michael D.

AU - Harris, Lucinda

AU - Jones, Michael P.

AU - Chang, Lin

PY - 2005/8

Y1 - 2005/8

N2 - Irritable bowel syndrome (IBS) is a multifactorial disorder characterized by abdominal pain and altered bowel habits. Chronic symptoms may occur due to changes in gastrointestinal motor function, enhanced perception of gut stimuli, and psychosocial factors. Recent data suggest that abnormal processing of afferent signals occurs in IBS patients. A newly recognized causative factor in a subset of IBS patients is postinfectious IBS. Altered transport of intestinal gas and bowel distention may contribute to abdominal discomfort, pain, and bloating. Changes in gut microflora have also been reported, but data remain scant. Advances have been made in our understanding of serotonin signaling and metabolism in IBS patients, in part due to the introduction of specific receptor agonists and antagonists. Finally, exciting data are emerging on genetic alterations that may contribute to the pathophysiology and treatment of IBS. Increasingly novel mechanisms are being identified that should aid in better understanding of the complex pathophysiology of IBS and developing new therapies.

AB - Irritable bowel syndrome (IBS) is a multifactorial disorder characterized by abdominal pain and altered bowel habits. Chronic symptoms may occur due to changes in gastrointestinal motor function, enhanced perception of gut stimuli, and psychosocial factors. Recent data suggest that abnormal processing of afferent signals occurs in IBS patients. A newly recognized causative factor in a subset of IBS patients is postinfectious IBS. Altered transport of intestinal gas and bowel distention may contribute to abdominal discomfort, pain, and bloating. Changes in gut microflora have also been reported, but data remain scant. Advances have been made in our understanding of serotonin signaling and metabolism in IBS patients, in part due to the introduction of specific receptor agonists and antagonists. Finally, exciting data are emerging on genetic alterations that may contribute to the pathophysiology and treatment of IBS. Increasingly novel mechanisms are being identified that should aid in better understanding of the complex pathophysiology of IBS and developing new therapies.

UR - http://www.scopus.com/inward/record.url?scp=24044548959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044548959&partnerID=8YFLogxK

M3 - Article

C2 - 16042910

AN - SCOPUS:24044548959

VL - 7

SP - 272

EP - 279

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 4

ER -